These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 8579010

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of hirulog-like peptide on balloon catheter injury-induced neointimal formation in femoral arteries of minipigs and relationship with inflammatory mediators.
    Tang XF, Liu JJ, Wu YJ, Chen KM, Jin Y, Gao PJ, Zhu DL, Shen GX.
    J Vasc Res; 2010; 47(3):262-9. PubMed ID: 19907188
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of the thrombin inhibitor r-hirudin in four animal models of neointima formation after arterial injury.
    Gerdes C, Faber-Steinfeld V, Yalkinoglu O, Wohlfeil S.
    Arterioscler Thromb Vasc Biol; 1996 Oct; 16(10):1306-11. PubMed ID: 8857929
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.
    Chamberlin JR, Lewis B, Leya F, Wallis D, Messmore H, Hoppensteadt D, Walenga JM, Moran S, Fareed J, McKiernan T.
    Can J Cardiol; 1995 Jun; 11(6):511-4. PubMed ID: 7780873
    [Abstract] [Full Text] [Related]

  • 8. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Leadley RJ, Kasiewski CJ, Bostwick JS, Bentley R, McVey MJ, White FJ, Perrone MH, Dunwiddie CT.
    Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction.
    Théroux P, Pérez-Villa F, Waters D, Lespérance J, Shabani F, Bonan R.
    Circulation; 1995 Apr 15; 91(8):2132-9. PubMed ID: 7697841
    [Abstract] [Full Text] [Related]

  • 11. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD, St Pierre A, Leblond L, Deschenes I, DiMaio J, Winocour PD.
    Thromb Haemost; 1998 Feb 15; 79(2):431-8. PubMed ID: 9493603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
    White HD, Aylward PE, Frey MJ, Adgey AA, Nair R, Hillis WS, Shalev Y, Brown MA, French JK, Collins R, Maraganore J, Adelman B.
    Circulation; 1997 Oct 07; 96(7):2155-61. PubMed ID: 9337184
    [Abstract] [Full Text] [Related]

  • 14. Direct stenting limits sirolimus-eluting stent edge neointimal thickening.
    Guérin P, Gouëffic Y, Heymann MF, Pillet P, Al Habash O, Crochet D, Pacaud P, Loirand G.
    J Vasc Surg; 2007 Aug 07; 46(2):354-9. PubMed ID: 17664110
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness of hirulog in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.
    Sarembock IJ, Gertz SD, Thome LM, McCoy KW, Ragosta M, Powers ER, Maraganore JM, Gimple LW.
    J Vasc Res; 1996 Aug 07; 33(4):308-14. PubMed ID: 8695755
    [Abstract] [Full Text] [Related]

  • 16. Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects.
    Lidón RM, Théroux P, Juneau M, Adelman B, Maraganore J.
    Circulation; 1993 Oct 07; 88(4 Pt 1):1495-501. PubMed ID: 8403297
    [Abstract] [Full Text] [Related]

  • 17. Macro-porosity is necessary for the reduction of neointimal and medial thickening by external stenting of porcine saphenous vein bypass grafts.
    George SJ, Izzat MB, Gadsdon P, Johnson JL, Yim AP, Wan S, Newby AC, Angelini GD, Jeremy JY.
    Atherosclerosis; 2001 Apr 07; 155(2):329-36. PubMed ID: 11254903
    [Abstract] [Full Text] [Related]

  • 18. Assessment of thrombin inhibitor efficacy in a novel rabbit model of simultaneous arterial and venous thrombosis.
    Marsh Lyle E, Lewis SD, Lehman ED, Gardell SJ, Motzel SL, Lynch JJ.
    Thromb Haemost; 1998 Mar 07; 79(3):656-62. PubMed ID: 9531058
    [Abstract] [Full Text] [Related]

  • 19. Reduced acute thrombus formation results in decreased neointimal proliferation after coronary angioplasty.
    Unterberg C, Sandrock D, Nebendahl K, Buchwald AB.
    J Am Coll Cardiol; 1995 Dec 07; 26(7):1747-54. PubMed ID: 7594113
    [Abstract] [Full Text] [Related]

  • 20. Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease.
    Cannon CP, Maraganore JM, Loscalzo J, McAllister A, Eddings K, George D, Selwyn AP, Adelman B, Fox I, Braunwald E.
    Am J Cardiol; 1993 Apr 01; 71(10):778-82. PubMed ID: 8456753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.